Anticancer Drugs Market Set to Soar Projected Growth from USD 222.57 Billion in 2023 to USD 495.07 Billion by 2030 at a 12.1% CAGR

𝐀𝐧𝐭𝐢𝐜𝐚𝐧𝐜𝐞𝐫 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

The global anticancer drugs market is projected to grow substantially, driven by advancements in oncology research, increased prevalence of cancer worldwide, and growing investments in healthcare infrastructure. The market, valued at USD 150 billion in 2023, is expected to reach approximately USD 250 billion by 2030, with a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period from 2024 to 2030.

This press release provides insights into the anticancer drugs market, focusing on country-specific developments in Vietnam, Thailand, Japan, South Korea, Singapore, the US, and Europe. Key aspects such as mergers and acquisitions, trends, opportunities, and updates are covered.

𝐓𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞, 𝐬𝐢𝐦𝐩𝐥𝐲 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 :https://www.maximizemarketresearch.com/request-sample/37133/

𝐕𝐢𝐞𝐭𝐧𝐚𝐦: 𝐆𝐫𝐨𝐰𝐭𝐡 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐕𝐢𝐞𝐭𝐧𝐚𝐦

Vietnam's healthcare sector has shown a significant rise in investments in cancer treatment facilities. The government's push for affordable oncology medications has led to partnerships with key pharmaceutical firms like 𝐍𝐨𝐯𝐚𝐫𝐭𝐢𝐬 and 𝐑𝐨𝐜𝐡𝐞. Vietnam's market for anticancer drugs is anticipated to grow at a CAGR of 8%, driven by increased awareness and early cancer screening programs.

𝐓𝐡𝐚𝐢𝐥𝐚𝐧𝐝: 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐆𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐓𝐡𝐚𝐢𝐥𝐚𝐧𝐝

Thailand's anticancer drugs market is expected to experience a CAGR of 7.2%, supported by government-backed initiatives like universal healthcare. Companies like 𝐑𝐨𝐜𝐡𝐞 and Eli Lilly have recently announced partnerships with local firms to expand access to cancer therapies. Thailand's focus on medical tourism is also boosting demand for cutting-edge cancer treatments.

𝐉𝐚𝐩𝐚𝐧: 𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐉𝐚𝐩𝐚𝐧

Japan remains a leader in oncology innovations. The market growth, with a projected CAGR of 6.8%, is fueled by the aging population and the rise in cancer cases. Major developments include 𝐀𝐬𝐭𝐞𝐥𝐥𝐚𝐬 𝐏𝐡𝐚𝐫𝐦𝐚'𝐬 launch of next-generation cancer drugs and 𝐓𝐚𝐤𝐞𝐝𝐚 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬' acquisitions to strengthen its oncology pipeline. Japan continues to emphasize personalized medicine to enhance treatment outcomes.

𝐓𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞, 𝐬𝐢𝐦𝐩𝐥𝐲 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 :https://www.maximizemarketresearch.com/request-sample/37133/

𝐒𝐨𝐮𝐭𝐡 𝐊𝐨𝐫𝐞𝐚: 𝐂𝐨𝐧𝐬𝐨𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐒𝐨𝐮𝐭𝐡 𝐊𝐨𝐫𝐞𝐚

South Korea's anticancer drug market is projected to grow at a robust CAGR of 7.4%, attributed to advancements in immunotherapy and targeted therapies. Recent consolidations, such as 𝐂𝐞𝐥𝐥𝐭𝐫𝐢𝐨𝐧'𝐬 merger with 𝐒𝐚𝐦𝐬𝐮𝐧𝐠 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬, underscore the nation's focus on innovation in biopharmaceuticals. South Korea is also investing heavily in R&D for biosimilars to reduce cancer treatment costs.

𝐒𝐢𝐧𝐠𝐚𝐩𝐨𝐫𝐞: 𝐔𝐩𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐒𝐢𝐧𝐠𝐚𝐩𝐨𝐫𝐞

Singapore is becoming a regional hub for oncology drug development. The market, with a CAGR of 7.9%, is supported by government policies fostering innovation and partnerships. Recent investments by 𝐁𝐫𝐢𝐬𝐭𝐨𝐥-𝐌𝐲𝐞𝐫𝐬 𝐒𝐪𝐮𝐢𝐛𝐛 and 𝐀𝐬𝐭𝐫𝐚𝐙𝐞𝐧𝐞𝐜𝐚 aim to establish clinical trial centers in Singapore, making it a key player in Asia-Pacific.

𝐔𝐧𝐢𝐭𝐞𝐝 𝐒𝐭𝐚𝐭𝐞𝐬: 𝐆𝐫𝐨𝐰𝐭𝐡 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐒

The US anticancer drugs market dominates globally, with a projected CAGR of 7.1%. Major mergers and acquisitions, such as 𝐌𝐞𝐫𝐜𝐤'𝐬 acquisition of 𝐀𝐜𝐜𝐞𝐥𝐞𝐫𝐨𝐧 𝐏𝐡𝐚𝐫𝐦𝐚, are driving innovation in the sector. The US remains a leader in immuno-oncology and CAR-T therapies, with increasing FDA approvals for advanced cancer drugs.

𝐓𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞, 𝐬𝐢𝐦𝐩𝐥𝐲 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 :https://www.maximizemarketresearch.com/request-sample/37133/

𝐄𝐮𝐫𝐨𝐩𝐞: 𝐓𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐂𝐨𝐧𝐬𝐨𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞

Europe is witnessing a surge in the adoption of precision medicine and biosimilars. The market is expected to grow at a CAGR of 6.7%. Recent developments include 𝐒𝐚𝐧𝐨𝐟𝐢'𝐬 acquisition of 𝐊𝐲𝐦𝐚𝐛 to expand its monoclonal antibody portfolio. The EU's focus on cross-border healthcare collaboration is paving the way for widespread access to innovative cancer treatments.

𝐀𝐧𝐭𝐢𝐜𝐚𝐧𝐜𝐞𝐫 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

𝐁𝐲 𝐃𝐫𝐮𝐠 𝐓𝐲𝐩𝐞

Cytotoxic Drugs
Alkylating Agents
Antimetabolites
Others
Targeted Drugs
Monoclonal Antibodies
Tyrosine Kinase Inhibitors
Others
Hormonal Drugs
Others

𝐁𝐲 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐓𝐲𝐩𝐞

Chemotherapy
Targeted Therapy
Immunotherapy
Others

𝐁𝐲 𝐂𝐚𝐧𝐜𝐞𝐫 𝐓𝐲𝐩𝐞

Breast Cancer
Lung Cancer
Stomach Cancer
Colorectal Cancer
Prostate Cancer
Liver Cancer
Others

𝐁𝐲 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

𝐅𝐨𝐫 𝐚 𝐝𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐨𝐯𝐞𝐫𝐯𝐢𝐞𝐰, 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 𝐩𝐫𝐨𝐯𝐢𝐝𝐞𝐝:https://www.maximizemarketresearch.com/market-report/anticancer-drugs-market/37133/

𝐀𝐧𝐭𝐢𝐜𝐚𝐧𝐜𝐞𝐫 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

𝐆𝐥𝐨𝐛𝐚𝐥

1. Roche (F. Hoffmann-La Roche Ltd) (Basel, Switzerland)
2. Novartis (Basel, Switzerland)
3. Pfizer (New York City, New York, USA)
4. Merck & Co., Inc. (Merck Sharp & Dohme Corp.) (Kenilworth, New Jersey, USA)
5. Bristol Myers Squibb (New York City, New York, USA)

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚

1. Eli Lilly and Company (Indianapolis, Indiana, USA)
2. Johnson & Johnson (New Brunswick, New Jersey, USA)
3. Celgene Corporation (Summit, New Jersey, USA)
4. Gilead Sciences (Foster City, California, USA)
5. Amgen (Thousand Oaks, California, USA)
6. Incyte Corporation (Wilmington, Delaware, USA)

𝐄𝐮𝐫𝐨𝐩𝐞

1. AstraZeneca (Cambridge, United Kingdom)
2. Sanofi (Paris, France)
3. Merck KGaA (Darmstadt, Germany)
4. Ipsen (Paris, France)

𝐀𝐬𝐢𝐚 𝐏𝐚𝐜𝐢𝐟𝐢𝐜

1. Takeda Pharmaceutical Company Limited (Tokyo, Japan)
2. Eisai Co., Ltd. (Tokyo, Japan
3. Astellas Pharma Inc. (Tokyo, Japan)
4. Daiichi Sankyo Company, Limited (Tokyo, Japan)
5. Kyowa Kirin Co., Ltd. (Tokyo, Japan)
6. Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan)
7. Shionogi & Co., Ltd. (Osaka, Japan)
8. Taiho Pharmaceutical Co., Ltd. (Tokyo, Japan)

𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐖𝐡𝐚𝐭'𝐬 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠:

♦ Laboratory Centrifuge Market https://www.maximizemarketresearch.com/market-report/laboratory-centrifuge-market/39476/

♦ Lactose Intolerance Treatment Market https://www.maximizemarketresearch.com/market-report/lactose-intolerance-treatment-market/88724/

♦ Malaysia Bioinformatics Market https://www.maximizemarketresearch.com/market-report/malaysia-bioinformatics-market/225341/

♦ Maternal Health Market https://www.maximizemarketresearch.com/market-report/maternal-health-market/189366/

♦ Meat Testing Market https://www.maximizemarketresearch.com/market-report/meat-testing-market/11187/

♦ Medical Billing Outsourcing Market https://www.maximizemarketresearch.com/market-report/medical-billing-outsourcing-market/199677/

♦ Microbiome Therapeutics Market https://www.maximizemarketresearch.com/market-report/microbiome-therapeutics-market/148468/

♦ Microfluidics Market https://www.maximizemarketresearch.com/market-report/microfluidics-market/164690/

♦ Microneedle Drug Delivery Systems Market https://www.maximizemarketresearch.com/market-report/microneedle-drug-delivery-systems-market/215694/

♦ Mother Child Healthcare Market https://www.maximizemarketresearch.com/market-report/mother-child-healthcare-market/187324/

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

𝐀𝐛𝐨𝐮𝐭 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.